Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The

Tagged with: , , , , , , , , , , , , , , ,

PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD

Tagged with: , , , , , , , , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTech’s BioRadio and Vivonoetic Inc.’s VivoSense Used in Prematurity and Respiratory Outcomes Program Multicenter Study

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 1, 2011 – Great Lakes NeuroTech’s BioRadio and Vivonoetics Inc.’s VivoSense software are being used for the Prematurity and Respiratory Outcomes Program  (PROP, http://www.urmc.rochester.edu/pediatrics/pedsnews/july-10/prop.cfm) multicenter clinical study to examine the respiratory outcome

Tagged with: , , , , , , , , , , , , , , , , , , , ,